Skip to main content
logo
Contineum Therapeutics, Inc. (CTNM)
NASDAQ: CTNM · Real-Time Price · USD
14.19
-1.11 (-7.25%)
Aug 14, 2026, 4:00 PM EDT - Market closed

Contineum Therapeutics Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
---50--
Revenue Growth
------
Gross Profit
---50--
Operating Income
-66.38-68.06-50.8916.08-22.72-28.65
Net Income
-57.56-59.98-42.263.15-24.25-29
Earnings Per Share
-1.72-2.17-2.180.08-10.81-13.77
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
236.55262.9204.76125.1947.2469
Total Debt
6.578.256.260.575.854.91
Net Cash (Debt)
229.98254.65198.5124.6241.3964.1
Net Cash Growth
35.49%28.28%59.29%201.08%-35.42%-
Net Cash Per Share
6.879.1910.2636.7018.4530.39

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-53.01-55.31-32.8519.35-20.12-26.27
Capital Expenditures
-0.46-0.23-0.51-0.41-0.12-0.17
Free Cash Flow
-53.46-55.54-33.3618.94-20.24-26.43
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
---100.00%--
Operating Margin
---32.15%--
Pretax Margin
---46.34%--
Profit Margin
---6.29%--
FCF Margin
---37.87%--

Valuation
Selected indicators aren't available for this stock.